Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.
about
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of ImmunotherapyChimeric Antigen Receptors Modified T-Cells for Cancer TherapyAdoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptorsThe importance of animal models in tumor immunity and immunotherapyTherapeutic cancer vaccines: past, present, and futureCAR therapy: the CD19 paradigmThe basic principles of chimeric antigen receptor design.Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccineProtumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion.Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.Adoptive immunotherapy of metastatic breast cancer: present and future.OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.Adoptive Cell Therapy in Multiple Myeloma.Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy.Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization.Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance
P2860
Q26745444-6F78D825-98A9-4B0E-A94F-67A47072E625Q26773309-C3DC4749-4992-4559-AF84-C734E0D13E88Q26795540-61BD09B1-D8F2-4876-ABA1-3174D935AEF7Q26823861-3DDC718E-6F3F-4814-9452-35E3B27B09C6Q26863283-3314998B-0780-4D44-A14F-4B17DA3A66FCQ28081642-ED0B42C7-61BC-4E99-96A8-FECFBC8B6B0FQ34036213-DB8550AF-1904-43B6-8E78-01A3E3E5E336Q36702887-6A1ED87C-EB3E-4190-80DD-CD0BBE5ACE1BQ36729107-7A6F62E1-9D88-4D9D-AB31-A63495897DAFQ38116358-E692FC19-1F0B-439C-AA72-DD28246B24E1Q38171325-9865353E-5435-4CF6-8B8D-057809E6B625Q38374889-33559B88-B36D-4A07-B74F-E10EDFCCA59FQ38635138-11D8C320-1681-491A-BCB2-3D0BD2D72D55Q40223950-5C7CA4ED-4354-412E-A696-5A09D58076E7Q41432593-0C084C0A-57E6-442B-A43B-EA9FEC4916A5Q43663422-7FF36CFB-365C-4CEA-A744-16485077C4E8Q43725536-F84B468B-0194-4AC6-AE4A-B4F2A5C46755Q43891437-733DFF1D-C06D-463E-BB1F-78D5A2B99991Q45395844-41FE35F9-6B21-4628-8A8A-49EA47BB44DAQ57167969-A306676F-7F1C-47A3-8149-EB77D0AB9081
P2860
Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.
@en
type
label
Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.
@en
prefLabel
Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.
@en
P2860
P356
P1476
Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.
@en
P2093
Hyam Levitsky
P2860
P304
P356
10.1155/2012/124187
P5008
P577
2012-05-31T00:00:00Z